Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...

While often perceived as a women's disease, breast cancer affects men as well. Stigma, however, can delay diagnosis and treatment, potentially...

Research has uncovered the role of the p53 gene in ulcerative colitis, suggesting a potential new drug target to prevent disease progression to...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...

In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...

Drugs designed to target HER2-positive breast cancer could also benefit some patients with bile duct cancer, according to results of a patient trial...

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can...

Once diagnosed with breast cancer, a patient will undergo management and treatment depending on the need.

A team of researchers from Beijing Anzhen Hospital and other institutions recently conducted a study that sheds light on the connection between blood...